[Trends of Radiotheranostics Research]

Area of Science:

• Nuclear medicine
• Radiochemistry
• Oncology

Background:

• Radiotheranostics merges diagnostic imaging and therapeutic applications using targeted radiolabeled compounds.
• This nuclear medicine approach offers a powerful tool for cancer management.

Purpose of the Study:

• To explore the strategic application of radiotheranostics, differentiating between combined imaging-therapy and sequential or individual use.
• To emphasize the importance of selecting appropriate radionuclides, including alpha emitters, for optimal therapeutic outcomes.

Main Methods:

• Review of current radiotheranostic strategies.
• Analysis of radionuclide properties (beta vs. alpha emitters) for therapeutic efficacy.
• Consideration of disease-specific requirements for tailoring treatment.

Main Results:

• Radiotheranostics can be effectively implemented as a combined or sequential therapy, depending on the specific disease context.
• Optimizing the use of alpha emitters alongside traditional beta emitters enhances therapeutic potential.
• The flexibility of radiotheranostic application is key to maximizing its benefits.

Conclusions:

• Radiotheranostic strategies should be tailored to individual diseases, recognizing that combined imaging and therapy are not always necessary.
• The judicious selection and application of radionuclides, particularly alpha emitters, are crucial for effective cancer treatment.
• Future advancements in radiotheranostics promise significant benefits for personalized medicine.